Sy, Eduardo C.

HRN: 21-46-57  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/26/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/26/2022
07/03/2022
IV
2.25gm
Q8
CBC
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Guideline Not Available

Initial appropriateness: Yes   

Final appropriateness: No  Wrong Dose  Wrong Dose

Overall appropriateness: No  Wrong Dose

Intervention



Type of Intervention done:

                    

           


Acceptance: